Published in Gene on February 14, 1993
LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro. Nucleic Acids Res (2006) 2.22
Budding of equine infectious anemia virus is insensitive to proteasome inhibitors. J Virol (2002) 1.67
A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J Virol (2009) 1.63
Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. J Virol (1997) 1.58
Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus. J Virol (2000) 1.47
Linear plasmid vector for cloning of repetitive or unstable sequences in Escherichia coli. Nucleic Acids Res (2009) 1.42
Temperature- and H-NS-dependent regulation of a plasmid-encoded virulence operon expressing Escherichia coli hemolysin. J Bacteriol (2002) 1.35
Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids. J Virol (2000) 1.24
Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection. J Virol (2001) 1.24
Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. J Virol (1998) 1.22
Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies. J Virol (2001) 1.09
Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein. J Virol (1995) 1.07
Modulation of horizontally acquired genes by the Hha-YdgT proteins in Salmonella enterica serovar Typhimurium. J Bacteriol (2007) 1.03
Induction of the Yersinia pestis PhoP-PhoQ regulatory system in the flea and its role in producing a transmissible infection. J Bacteriol (2013) 1.01
The Hha protein as a modulator of expression of virulence factors in Escherichia coli. Infect Immun (1996) 0.97
Construction of a genome-length cDNA clone for human astrovirus serotype 1 and synthesis of infectious RNA transcripts. J Virol (1997) 0.96
radC102 of Escherichia coli is an allele of recG. J Bacteriol (2000) 0.89
Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus. Clin Vaccine Immunol (2008) 0.88
Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus. J Virol (2004) 0.83
Disease induction by virus derived from molecular clones of equine infectious anemia virus. J Virol (1998) 0.82
Functional replacement of the oligomerization domain of H-NS by the Hha protein of Escherichia coli. J Bacteriol (2005) 0.79
Development of an equine-tropic replication-competent lentivirus assay for equine infectious anemia virus-based lentiviral vectors. Hum Gene Ther Methods (2012) 0.77
Efficient generation of recombinant influenza A viruses employing a new approach to overcome the genetic instability of HA segments. PLoS One (2015) 0.75
A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res Hum Retroviruses (1989) 7.34
Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J Virol (1995) 4.92
Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature (1986) 4.35
Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J Virol (1997) 4.08
Assembly of type C oncornaviruses: a model. Science (1978) 3.53
A formalin-inactivated whole SIV vaccine confers protection in macaques. Science (1989) 3.37
Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus. Virology (1986) 3.24
Nucleotide sequence of the transforming gene of avian myeloblastosis virus. Science (1982) 3.12
Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus. J Biol Chem (1984) 3.02
Euglena gracilis chloroplast ribosomal RNA transcription units. II. Nucleotide sequence homology between the 16 S--23 S ribosomal RNA spacer and the 16 S ribosomal RNA leader regions. J Biol Chem (1980) 2.96
Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly. J Virol (1998) 2.68
Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection. J Virol (1986) 2.42
Reversible staining and peptide mapping of proteins transferred to nitrocellulose after separation by sodium dodecylsulfate-polyacrylamide gel electrophoresis. Anal Biochem (1986) 2.07
Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J Virol (1995) 2.01
Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J Virol (1997) 2.00
The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles. Biochemistry (2001) 1.88
Distinct subsets of retroviruses encode dUTPase. J Virol (1992) 1.80
Simian immunodeficiency virus/delta-induced immunodeficiency disease in rhesus monkeys: relation of antibody response and antigenemia. J Infect Dis (1988) 1.75
Escherichia coli delta 1-pyrroline-5-carboxylate reductase: gene sequence, protein overproduction and purification. Nucleic Acids Res (1982) 1.75
Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J Infect Dis (1998) 1.71
Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology (1993) 1.67
An analysis of type-C retrovirus polypeptides and their associations in the virion. Virology (1978) 1.65
Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV. Virology (1987) 1.64
Isolation and comparative biochemical properties of the major internal polypeptides of equine infectious anemia virus. J Virol (1982) 1.64
A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides. AIDS Res Hum Retroviruses (1991) 1.62
Purification and characteristics of a gamma-glutamyl kinase involved in Escherichia coli proline biosynthesis. J Bacteriol (1984) 1.61
Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. J Virol (1997) 1.58
Analysis of the Escherichia coli proBA locus by DNA and protein sequencing. Nucleic Acids Res (1984) 1.53
Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain. Virology (2001) 1.52
Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. J Virol (1995) 1.50
Radiolabeling of proteins and viruses in vitro by acetylation with radioactive acetic anhydride. J Biol Chem (1975) 1.49
Characterization of infectious molecular clones of equine infectious anaemia virus. J Gen Virol (1994) 1.49
Virulence and in vitro growth of a cell-adapted strain of equine infectious anemia virus after serial passage in ponies. Am J Vet Res (1982) 1.45
A general model for the surface glycoproteins of HIV and other retroviruses. AIDS Res Hum Retroviruses (1995) 1.42
Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies. J Virol (1992) 1.41
Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections. J Virol (1998) 1.38
Equine infectious anemia virus, a putative lentivirus, contains polypeptides analogous to prototype-C oncornaviruses. Virology (1980) 1.36
Novel antimicrobial peptides derived from human immunodeficiency virus type 1 and other lentivirus transmembrane proteins. Antimicrob Agents Chemother (1997) 1.35
Course and extent of variation of equine infectious anemia virus during parallel persistent infections. J Virol (1987) 1.33
Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant. J Virol (1993) 1.32
Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J Virol (1992) 1.32
Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein. AIDS Res Hum Retroviruses (1993) 1.32
Characterization of a Euglena gracilis chloroplast RNA polymerase specific for ribosomal RNA genes. J Biol Chem (1985) 1.26
Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection. J Virol (2001) 1.24
Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids. J Virol (2000) 1.24
Antigenic variation in lentiviral diseases. Annu Rev Immunol (1988) 1.23
Efficacy of SIV/deltaB670 glycoprotein-enriched and glycoprotein-depleted subunit vaccines in protecting against infection and disease in rhesus monkeys. AIDS (1991) 1.23
Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. J Virol (1998) 1.22
Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus. J Virol (2000) 1.21
Nucleotide sequence analysis of the long terminal repeat of avian myeloblastosis virus and adjacent host sequences. J Virol (1982) 1.21
The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro. J Virol (1998) 1.20
Production and characterization of SIV envelope-specific rhesus monoclonal antibodies from a macaque asymptomatically infected with a live SIV vaccine. AIDS Res Hum Retroviruses (1998) 1.20
Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection. Arch Virol (1990) 1.18
Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. J Virol (1987) 1.17
Preparative elution of proteins from nitrocellulose membranes after separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal Biochem (1985) 1.17
Calmodulin-binding function of LLP segments from the HIV type 1 transmembrane protein is conserved among natural sequence variants. AIDS Res Hum Retroviruses (1997) 1.17
Development of a multiplex real-time reverse transcriptase-polymerase chain reaction for equine infectious anemia virus (EIAV). J Virol Methods (2002) 1.15
Genomic alterations associated with persistent infections by equine infectious anaemia virus, a retrovirus. J Gen Virol (1984) 1.13
Lentivirus-derived antimicrobial peptides: increased potency by sequence engineering and dimerization. J Antimicrob Chemother (1999) 1.13
In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV). Arch Virol (1990) 1.13
Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus. J Virol Methods (1998) 1.12
A survey of potential problems and quality control in peptide synthesis by the fluorenylmethoxycarbonyl procedure. Pept Res (1992) 1.10
Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. Virology (1994) 1.09
Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies. J Virol (2001) 1.09
Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement. Virology (1998) 1.09
Effect of amino acid substitutions on calmodulin binding and cytolytic properties of the LLP-1 peptide segment of human immunodeficiency virus type 1 transmembrane protein. J Virol (1995) 1.08
Proteins of Rous-associated virus type 61: polypeptide stoichiometry and evidence that glycoprotein gp35 is not a cleavage product of gp85. J Virol (1977) 1.08
Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein. J Virol (1995) 1.07
On the use of chloramine-T to iodinate specifically the surface proteins of intact enveloped viruses. J Gen Virol (1975) 1.07
Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections. J Virol (1990) 1.07
A comparison of the mobilities and thermal transitions of retrovirus lipid envelopes and host cell plasma membranes by electron spin resonance spectroscopy. Biochim Biophys Acta (1982) 1.04
Selective in vitro transcription of Euglena chloroplast ribosomal RNA genes by a transcriptionally active chromosome. J Biol Chem (1980) 1.03
A versatile synthetic peptide-based ELISA for identifying antibody epitopes. J Immunol Methods (1994) 1.03
The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies. J Virol (2000) 1.03
Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus. J Virol (1996) 1.03
Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus. Virology (1999) 1.02
Intracellular proteins of feline immunodeficiency virus and their antigenic relationship with equine infectious anaemia virus proteins. J Gen Virol (1990) 1.02
Structure and morphogenesis of type-C retroviruses. Adv Cancer Res (1978) 1.02
Enzyme-linked immunosorbent assay for detection of equine infectious anemia virus p26 antigen and antibody. J Clin Microbiol (1984) 0.99
Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core. Cancer Res (1993) 0.99
Developments in preclinical AIDS vaccine efficacy models. AIDS (2000) 0.99
Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus. J Virol (1991) 0.99
EIAV genomic organization: further characterization by sequencing of purified glycoproteins and cDNA. Virology (1988) 0.98
A synthetic peptide corresponding to the carboxy terminus of human immunodeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xenopus laevis oocytes. AIDS Res Hum Retroviruses (1997) 0.98
Further characterization of the oncornavirus inactivating factor in normal mouse serum. Virology (1979) 0.98
Detection of equine infectious anemia viral RNA in plasma samples from recently infected and long-term inapparent carrier animals by PCR. J Clin Microbiol (1996) 0.98
Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV. Immunol Cell Biol (1997) 0.96
A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus. Virology (1999) 0.96
Differential responses of Equus caballus and Equus asinus to infection with two pathogenic strains of equine infectious anemia virus. Vet Microbiol (2001) 0.96
Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2. J Virol (1992) 0.95